High Doses of Total End Range Time Offer Better Results Than Low Doses Treating Proximal Interphalangeal Joint Stiffness

NCT05625451 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
91
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Vicenç Punsola Izard